Stephen Parodi, MD, tells CNN that future COVID-19 outbreaks could be managed like seasonal flu
Kaiser Permanente's national infectious disease leader suggests the COVID-19 pandemic will transition into its “endemic” phase in 2022.
Younger children waiting for COVID-19 vaccines need to be protected, Stephen Parodi, MD, tells CNN
Stephen Parodi, MD, national infectious disease leader at Kaiser Permanente, stresses the importance of public health protective measures until the vaccine is broadly available for children under 5.
Stephen Parodi, MD, tells CNN International vaccine mandates effectively increase rates among employees
The Permanente Medical Group associate executive director says vaccination rates are above 96% for all Kaiser Permanente employees and 98% for Permanente physicians in California.
Stephen Parodi, MD, speaks with CNN International about coronavirus variants, boosters
Kaiser Permanente’s national infectious disease leader says 99% of hospitalizations in California are among people who remain unvaccinated.
Stephen Parodi, MD, discusses U.S. resumption of Johnson & Johnson COVID-19 vaccine
Kaiser Permanente infectious disease leader says physicians now have a huge task to restore confidence in vaccines.
Comilla Sasson, MD, shares her experience on the front lines of COVID-19 with CNN
The Permanente emergency medicine physician offers her first-hand account of addressing the COVID-19 pandemic across 8 states.
Matthew Daley, MD, shares hopes for 3rd COVID vaccine with CNN and Washington Post
The Permanente pediatrician, a member of an FDA vaccine advisory panel, commented on how the recently approved Johnson & Johnson vaccine can aide in ending the pandemic.
Stephen Parodi, MD, calls third COVID-19 vaccine a “huge game changer” on CNN International
Permanente infectious disease leader Stephen Parodi, MD, underscores the importance of the recently authorized 1-dose Johnson & Johnson vaccine in preventing hospitalizations and deaths.
CNN International talks to Stephen Parodi, MD, about COVID vaccine supply and demand
Kaiser Permanente's national infectious disease leader says that the organization is working with the state and the federal government to inform them on COVID-19 vaccine supply needs.
Stephen Parodi, MD, discusses COVID-19 vaccine mobilization effort
Kaiser Permanente’s national infectious disease leader expressed confidence in the safety and efficacy of the vaccine, given the organization’s participation in Pfizer-BioNTech COVID-19 vaccine trials.